Toggle light / dark theme

UC Berkeley Conference on Aging and Longevity: Gregory Fahy, Wei-Wu He, and Andreas Stahl

On Sunday, July 19, 2026, at 1 p.m. U.S. Pacific Time, watch the third compilation stream, consisting of three additional presentations from the May 3, 2026, sessions at the University of California, Berkeley Conference on Aging and Longevity (BerkeleyCAL), hosted by Professor Steven A. Garan, Director of Bioinformatics at the Center for Research and Education on Aging.

These presentations delve into cutting-edge science, including actual human trials on rejuvenation, efforts to improve human longevity through genetic screening, and models of senescence at the cellular level. They are delivered by renowned longevity researchers Gregory Fahy, Wei-Wu He, and Andreas Stahl. The presentations include question-and-answer sessions, including questions posed by U.S. Transhumanist Party Chairman Gennady Stolyarov II to Andreas Stahl.

Dr. Greg Fahy of Intervene Immune presents evidence that thymic involution—the age-related decline of the thymus gland—is a primary driver of immune failure and various age-related diseases, including cancer and cardiovascular issues. To address this, he details the multiple TRIIM clinical trials in small cohorts of human patients, which successfully demonstrate that a combination of growth hormone, DHEA, and metformin can safely regenerate functional thymic tissue and rejuvenate the immune system.

Dr. Wei-Wu He of Human Longevity, Inc., emphasizes the critical importance of whole-genome sequencing for personalized longevity and healthcare, noting that genetics account for approximately 50–55% of an individual’s healthspan and lifespan. Reflecting on the legacy of Human Longevity, Inc. founder Dr. J. Craig Venter (1946−2026), Dr. He’s presentation advocates for utilizing genomic data alongside AI and advanced clinical diagnostics to shift from reactive sick care to proactive, data-driven prevention. Dr. He highlights new, accessible initiatives to bring comprehensive genomic analysis and proteomic testing to the public to help individuals identify and manage their unique health risks.

Dr. Andreas Stahl of UC Berkeley presents a microphysiological \.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */